About Us

Advanced Cancer Diagnostics mission is to make available to as wide an audience as possible throughout the UK & Ireland Chronix Biomedical’s cancer diagnostics technology.

We believe this is a breakthrough in the early diagnosis of cancer and will lead to better patient outcomes, not just in the years to come but today.

Chronix Biomedical

Chronix Biomedical, Inc.

Chronix Biomedical, Inc. is a molecular diagnostics company offering laboratory developed blood tests for screening and monitoring cancer through its own certified laboratories. Chronix is privately held with headquarters in San Jose, California, and laboratories in Göttingen, Germany. Currently, Chronix Biomedical has offered 4 different tests.

CNI Second Opinion™

Chronix Biomedical tests are blood tests that can be used on the finding of elevated levels of PSA (for men at risk of prostate cancer), or abnormalities in examining women’s breast (risk of breast cancer) and before biopsy. Second Opinion ™ test can reduce the number of unnecessary biopsies and discomfort associated with them, and unwanted side effects in a small number of cases.

Chronix Second Opinion ™
Delta Dot Treatment Outcome Evaluation Test

CNI Monitor

The Chronix Biomedical CNI Cancer Monitor blood test is a vast improvement over the current methods of determing whether a patient is responding to therapy or not. The essential difference is that now for the first time, due to Next Generation Sequencing we can detect cancer mutations of DNA in blood plasma. Advantages of this new technology, are that we can now look at the entirety of the body relating to cancer. Current scanning and tissue biopsy can only look at a specific part of the body.

CNI Screen

The Chronix Biomedical CNI Cancer Screen test is a vast improvement to more traditional methods of determing the presence of cancer. The essential difference is that now for the first time, due to Next Generation Sequencing we can detect cancer mutations of DNA in blood plasma. Advantages of this new technology, are that we can now look at the entirety of the body and its health state relating to cancer. Current scanning and tissue biopsy can only look at a specific part of the body, such as the lung or prostate, and is usually only carried out on presentation of symptoms.

CNI Cancer Evaluation Test

Our Mission

Advanced Cancer Diagnostics mission is to make available to as wide an audience as possible throughout the UK & Ireland Chronix Biomedical’s cancer diagnostics technology. We believe this is a breakthrough in the early diagnosis of cancer and will lead to better patient outcomes, not just in the years to come but today.

Medical Staff

Dr. Andrzej Borkowski

Dr. Andrzej Borkowski

Professor Medicine University of Warsaw, Head of Urology 1992 ‒ 2012. His main…

ACD Team

marta

Marta Łowicka

 

Originally from Poland, where I got a master’s degree in finance and management. Now brings this organisational skill to Advanced Cancer Diagnostics working with clinics and clients to ensure the smooth running of our clinical operations.

Helen Dodd

Helen Dodd

Nurse Specialist

Prior to joining Advanced Cancer Diagnostics Helen worked for many years in an administrative capacity in the NHS before graduating with a first Class Honors…